Mathur Sachin, Peng Szelin, Gane Edward J, McCall John L, Plank Lindsay D
Department of Surgery, University of Auckland, Auckland, New Zealand.
Nutrition. 2007 May;23(5):398-403. doi: 10.1016/j.nut.2007.02.003. Epub 2007 Mar 29.
A subgroup of cirrhotic patients develop hypermetabolism, possibly mediated by increased sympathetic nervous system activity and increased cardiac output. The effect of hypermetabolism on prognosis in patients with cirrhosis has not been elucidated.
Resting energy expenditure (REE) was measured using indirect calorimetry in 256 cirrhotic patients with different etiologies and disease severity (165 men, 91 women; median age 49 y, age range 16-73 y; median model for end-stage liver disease [MELD] score 13, range 6-36; median Child-Pugh score 8, range 5-15). Measured and predicted values were compared using equations based on fat-free mass, total body protein (measured by neutron activation analysis), and the Harris-Benedict equations. Competing-risks Cox's proportional hazards analysis was performed to evaluate the influence of hypermetabolism and MELD or Child-Pugh scores on risk of death or liver transplantation.
Median follow-up was 49 mo (range 1-90 mo). Hypermetabolic patients had decreased transplant-free survival compared with non-hypermetabolic patients (9.7 versus 31.8 mo, P = 0.05). Increased REE, even within the normal range, was also associated with worse transplant-free survival (P = 0.001). Hypermetabolism was predictive of transplant-free survival independent of MELD and Child-Pugh scores (hazard ratio 1.19, 95% confidence interval 1.08-1.32, P = 0.0008; hazard ratio 1.13, 95% confidence interval 1.10-1.16, P < 0.0001; hazard ratio 1.38, 95% confidence interval 1.29-1.48, P < 0.0001; respectively). Patients on beta-blockers were more likely to be normometabolic (P = 0.035).
We found an inverse relation between REE and transplant-free survival in a large heterogeneous group of cirrhotic patients.
一部分肝硬化患者会出现高代谢,可能是由交感神经系统活动增加和心输出量增加介导的。高代谢对肝硬化患者预后的影响尚未阐明。
采用间接测热法测量了256例不同病因和疾病严重程度的肝硬化患者的静息能量消耗(REE)(165例男性,91例女性;中位年龄49岁,年龄范围16 - 73岁;终末期肝病模型[MELD]评分中位数13,范围6 - 36;Child-Pugh评分中位数8,范围5 - 15)。使用基于去脂体重、全身蛋白质(通过中子活化分析测量)和Harris-Benedict方程的公式比较测量值和预测值。进行竞争风险Cox比例风险分析,以评估高代谢和MELD或Child-Pugh评分对死亡或肝移植风险的影响。
中位随访时间为49个月(范围1 - 90个月)。与非高代谢患者相比,高代谢患者的无移植生存期缩短(9.7个月对31.8个月,P = 0.05)。即使REE增加在正常范围内,也与较差的无移植生存期相关(P = 0.001)。高代谢可独立于MELD和Child-Pugh评分预测无移植生存期(风险比1.19,95%置信区间1.08 - 1.32,P = 0.0008;风险比1.13,95%置信区间1.10 - 1.16,P < 0.0001;风险比1.38,95%置信区间1.29 - 1.48,P < 0.0001;分别)。使用β受体阻滞剂的患者更可能代谢正常(P = 0.035)。
我们在一大组异质性肝硬化患者中发现REE与无移植生存期之间存在负相关。